Ads
related to: generic drug companies stockstwtrader.com has been visited by 10K+ users in the past month
get.dtitrader.com has been visited by 10K+ users in the past month
Search results
Maine mom searches for answers to shortage of ADHD drugs
WCSH 6 Portland· 16 hours agoDemand for the drugs has increased dramatically since 2022 and the Food and Drug Administration...
Implied Volatility Surging for Amphastar (AMPH) Stock Options
Zacks· 2 days agoFree Report) need to pay close attention to the stock based on moves in the options market lately. What is Implied Volatility? Implied volatility shows how much movement the ...
Earnings call: Paysign reports strong Q1 growth, optimistic outlook By Investing.com
Investing.com· 5 days agoPaysign Inc. (PAYS) has announced a significant increase in its financial performance for the first...
Zacks Industry Outlook Highlights Mettler-Toledo and Bruker
Zacks· 2 days agoThe Zacks Instruments - Scientific industry is benefiting from increasing healthcare spending, driven by aging demography, and continued innovation in the pharma and life sciences end-markets ...
Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales
Zacks via Yahoo Finance· 3 days agoBayer's (BAYRY) Q1 earnings and sales decline year over year due to a fall in volumes for...
ANI Pharmaceuticals (NASDAQ:ANIP) Price Target Raised to $87.00 at HC Wainwright
ETF DAILY NEWS· 3 days agoANI Pharmaceuticals (NASDAQ:ANIP – Free Report) had its price target lifted by HC Wainwright from $83.00 to $87.00 in a research note issued to investors on Monday, Benzinga reports. They currently ...
Teva Pharmaceutical Industries (NYSE:TEVA) Downgraded to Buy at StockNews.com
ETF DAILY NEWS· 3 days agoPiper Sandler upgraded Teva Pharmaceutical Industries from a neutral rating to an overweight rating and boosted their price target for the stock from $12.00 to $19.00 in a ...
Unveiling Viatris (VTRS)'s Value: Is It Really Priced Right? A C
Guru Focus· 3 days agoWith a Loss Per Share of 0.06, the question arises: is Viatris modestly overvalued? This article delves into a detailed valuation analysis to help investors make informed decisions. Viatris ...
Bausch Health to defend patents against Norwich By Investing.com
Investing.com· 3 days agoIV certification notice on May 10, 2024, from Norwich. This notice informs Bausch Health of...
AGF Management Ltd. Cuts Position in McKesson Co. (NYSE:MCK)
ETF DAILY NEWS· 2 days ago(NYSE:MCK – Free Report) by 13.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 5,949 shares of the company’s stock< ...
